EyePoint Pharmaceuticals ... (EYPT)

EYPT trades at $13.9, 39.0% above the near-term max pain of $10 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$15), signaling increased put positioning or downside protection. Key magnetic zone at 10 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for EYPT shows a downward trend from 15 to 2.5, indicating bearish sentiment or hedging activity. The 133% spread signals divergent expectations across timeframes. Most levels below 13.9 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.